Clinical Trial Update: Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial update on rapid test-and-treat Dolutegravir plus Lamivudine in newly diagnosed HIV-1 adults; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dolutegravir (dolutegravir)
• Lamivudine (lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-04-28